Overview
Kadefarm distributes proctological and gynaecological products, including Posterisan® and the Ginovagin® medical device. It is the exclusive distributor in Poland of Posterisan® ointment and suppositories and Swiss Declaré® dermocosmetics.
Financials
Revenue history (in m)
Filing timeliness
Financial statements were filed on time, on average 93 days early. All were audited by a statutory auditor.
- 202528/04/2026
- 202416/04/2025
- 202322/04/2024
- 202204/05/2023
- 202111/05/2022
- 202002/05/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Trademarks
Kadefarm holds 23 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2005.
| Mark | Protected until | |
|---|---|---|
| GINOVAGIN KADEFARM | Feb 14, 2035 | |
| Mark without a word element(figurative) | Feb 1, 2034 | |
| SEPTOCADIN KADEFARM | Mar 19, 2030 | |
| DEZOCADIN KADEFARM | Mar 6, 2030 | |
| UROCADIN KADEFARM | Dec 19, 2029 |
Authorized Representatives
Manner of representation
Each member of the management board is authorized to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Dr. Kade Pharmazeutische Fabrik Gmbh | 50 | $13,506.21 | 50% |
Janusz Malickiage 66 | 50 | $13,506.21 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2005-08-01.
07 1050 1520 1000 0090 8109 9864- 36 1050 1520 1000 0090 8128 5679
- 45 1050 1520 1000 0090 8144 8962
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $562.8K$562,801 |
Buildings and premises | $746.1K$746,125 |
Public aid
6 public aid cases recorded, with a total value of $395,332.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $12,109$12,109 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $13,256$13,256 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $12,684$12,684 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Dopharma Polskasp. z o.o. | $21,009,985.91 | dopharma.com | ||
| Vitamed Pharmaceuticalssp. z o.o. | $14,515,124.01 | vitamed.pl | ||
| Pharmabestsp. z o.o. | $13,942,252.57 | pharmabest.pl | ||
| Valentis Polskasp. z o.o. | $13,271,939.35 | valentis.pl | ||
| Centrofarmsp. z o.o. | $13,105,870.20 | centrofarm.pl | ||
| Paso-Tradingsp. z o.o. | $12,314,433.40 | paso-trading.pl | ||
| Vipadosp. z o.o. | $11,385,128.54 | vipado.pl | ||
| ODA Medicalsp. z o.o. | $9,414,794.43 | odamedical.pl | ||
| Vet-Agro Tradingsp. z o.o. | $7,314,722.04 | vet-agro.pl | ||
| Pharm Supplysp. z o.o. | $6,901,751.00 | pharmsupply.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2018-05-28 | PKD change (Removed: 69.20.Z, 73.11.Z, 73.12.A, 73.12.B, 73.12.C, 73.12.D) | |
| 2010-10-11 | Switch to PKD 2007 (8 PKD 2004 codes → 16 PKD 2007 codes) | |
| 2010-04-28 | Address change (Bułgarska 65a, 60-320, Poznań → Gipsowa 18, 62-080, Sierosław) | |
| 2005-11-18 | Address change (Grochowska 29, 60-277, Poznań → Bułgarska 65a, 60-320, Poznań) | |
| 2005-09-08 | Entered in the register |
FAQ
Last updated: 2026-04-28